ScienceDex / Researcher record
Draganski, Andrew R
- Zylo Therapeutics, Inc. (no department on record)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
- Early Career
NIH Funding · FY2023
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2021 | $697,168 | 1 | #14,985 |
| 2022 | $1,571,504 | 3 | #5,220 |
| 2023 | $447,861 | 2 | #26,518 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY20211 record
- FY20223 records
- FY2023 · selected2 records
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2021 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2027.
FY2023 award records by amount
NIH award records listing Draganski, Andrew R as a PI. Multi-PI records show the full award amount for context.
- 5R41AI165204-02R41Contact PIDevelopment and optimization of a nitric oxide releasing microparticle-basedtopical treatment for onychomycosis$300Kaward amount
- 1R41AR082749-01R41Contact PIDevelopment of an endocannabinoid microparticle formulation for the topical treatment of cutaneous manifestations of lupus erythematosus.$147.9Kaward amount
Award organization
Organizations that administered FY2023 awards listing Draganski, Andrew R as a PI.
FY2023 award administered by Zylo Therapeutics, Inc. (SC).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2021First NIH AwardZylo Therapeutics, Inc.
- 2021$500K Cumulative Funding
- 2022$1M Cumulative Funding
- 2022$2M Cumulative Funding
- 2022Entered Top 50% NationallyRanked #5220